• COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
Buy Tests
  • COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
  • BUY TESTS
Scientific Discoveries: Latest COVID-19 Research on Transmission, Treatment, and Origins

Scientific Discoveries: Latest COVID-19 Research on Transmission, Treatment, and Origins

by Oceanit | Dec 16, 2024 | General, International News

Scientific Discoveries: Latest COVID-19 Research on Transmission, Treatment, and Origins COVID-19 continues to evolve, and so does our understanding of the virus. Recent research has uncovered critical insights into SARS-CoV-2 transmission dynamics, treatment...
Global COVID-19 Trends: Current Data on Cases and Deaths in 2024

Global COVID-19 Trends: Current Data on Cases and Deaths in 2024

by Oceanit | Dec 13, 2024 | Future, International News

Global COVID-19 Trends: Current Data on Cases and Deaths in 2024 As we near the end of 2024, COVID-19 continues to affect populations worldwide. Despite widespread vaccination efforts and public health measures, the global situation reflects varying trends in COVID-19...
COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025

COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025

by Oceanit | Dec 12, 2024 | Future, Government, International News

COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025 Global Impact of COVID-19: Countries Hardest Hit and Those Still Struggling in 2025 The COVID-19 pandemic has left a profound impact on nations worldwide, with some countries experiencing...
How COVID-19 Affected the Worlds of Sports and Entertainment

How COVID-19 Affected the Worlds of Sports and Entertainment

by Oceanit | Dec 9, 2024 | General, International News

How COVID-19 Affected the Worlds of Sports and Entertainment The COVID-19 pandemic has profoundly disrupted the industries around the world, from travel or doing business in-person. Among the sectors that were forever changed was sports and entertainment. Gatherings...
Learning from COVID-19 and Asymptomatic Spread

Learning from COVID-19 and Asymptomatic Spread

by Oceanit | Nov 19, 2024 | Future, International News

Learning from COVID-19 and Asymptomatic Spread An article on University of Maryland Biology Professor Joshua Weitz shares insights from the COVID-19 pandemic and discusses Prof. Weitz’s new book, Asymptomatic. In the book, Prof. Weitz emphasizes how COVID-19 is...
PRESS RELEASE | Oceanit’s ASSURE-100 Rapid COVID-19 Home Test Receives FDA Over-The-Counter Authorization

PRESS RELEASE | Oceanit’s ASSURE-100 Rapid COVID-19 Home Test Receives FDA Over-The-Counter Authorization

by Oceanit | Dec 22, 2022 | International News, National News

PRESS RELEASE | Oceanit’s ASSURE-100 Rapid COVID-19 Home Test Receives FDA Over-The-Counter Authorization FOR IMMEDIATE RELEASE | December 22, 2022 ASSURE-100’s over-the-counter (OTC) authorization permits at-home testing for anyone, with or without symptoms. FDA...
« Older Entries
Next Entries »

Recent Posts

  • New 2025 COVID Vaccine Rules: What They Mean for Americans
  • Summer 2025 COVID Trends: What to Know & How to Stay Safe
  • CDC Updates 2025 COVID-19 Testing, Isolation & Recovery
  • WHO Pandemic Treaty Aims to Prevent Future Health Crises
  • Should You Keep Rapid Tests for Spring & Summer 2025?

Recent Comments

No comments to show.
Copyright 2025 Oceanit Foundry LLC. The ASSURE-100 Rapid COVID-19 Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
[dsm_icon_list list_alignment=”flex-end” _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” list_alignment_last_edited=”on|phone” list_alignment_phone=”center” sticky_enabled=”0″ list_alignment_tablet=”flex-end”][dsm_icon_list_child text=”Privacy Policy” use_icon=”off” url=”/privacy-policy/” _builder_version=”4.27.4″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_text_color=”#e8e8e8″ text_font_size=”12px” text_text_color_last_edited=”off|desktop” global_colors_info=”{}” text_text_color__hover_enabled=”on|desktop” text_text_color__hover=”#1e73be”][/dsm_icon_list_child][/dsm_icon_list]